Irina V Alymova Selected Research

4- zido- 5- isobutyrylamino- 2,3- didehydro- 2,3,4,5- tetradeoxyglycerogalacto- 2- nonulopyranosic acid

9/2009	Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice.
1/2009	Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice - further evaluation.
9/2008	Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site.
1/2005	The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae.
5/2004	Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Irina V Alymova Research Topics

Disease

7	Human Influenza (Influenza) 01/2022 - 12/2011
7	Infections 01/2019 - 05/2004
7	Paramyxoviridae Infections (Parainfluenza) 02/2012 - 05/2004
2	Inflammation (Inflammations) 10/2018 - 01/2014
2	Superinfection 12/2017 - 01/2014
2	Bacterial Infections (Bacterial Infection) 01/2014 - 12/2011
2	Pneumonia (Pneumonitis) 01/2014 - 12/2011
1	Obesity 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Pneumococcal Pneumonia 01/2014
1	Weight Loss (Weight Reduction) 01/2014
1	Acute Lung Injury 12/2011
1	Body Weight (Weight, Body) 09/2008
1	Bacterial Pneumonia 01/2005
1	Virus Diseases (Viral Diseases) 01/2005

Drug/Important Bio-Agent (IBA)

7	Hemagglutinins (Hemagglutinin)IBA 10/2016 - 05/2004
7	Neuraminidase (Sialidase)IBA 02/2012 - 05/2004
5	4- zido- 5- isobutyrylamino- 2,3- didehydro- 2,3,4,5- tetradeoxyglycerogalacto- 2- nonulopyranosic acidIBA 09/2009 - 05/2004
4	Proteins (Proteins, Gene)FDA Link 10/2018 - 12/2011
2	VaccinesIBA 01/2022 - 05/2004
2	CytokinesIBA 01/2014 - 12/2011
2	Peptides (Polypeptides)IBA 01/2014 - 12/2011
2	V 70 (V70)IBA 01/2014 - 01/2014
2	Glycoproteins (Glycoprotein)IBA 02/2012 - 03/2010
2	4- dichloromethanesulfonylamino- 2,3- didehydro- 2,3,4,5- tetradeoxyglycerogalacto- 2- nonulopyranosic acidIBA 09/2009 - 05/2004
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022
1	AntigensIBA 01/2019
1	LectinsIBA 01/2019
1	Nonsense Codon (Nonsense Mutation)IBA 12/2017
1	peptide AIBA 01/2014
1	Viral ProteinsIBA 01/2014
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 09/2009
1	Dihydrotachysterol (AT 10)IBA 01/2005
1	Antiviral Agents (Antivirals)IBA 01/2005
1	HN ProteinIBA 05/2004

Therapy/Procedure

3	Therapeutics 01/2019 - 05/2004
2	Intranasal Administration 01/2005 - 05/2004